SIRT1 and fatty liver disease: Precisely, the effect of resveratrol on obesity and hepatic steatosis has been described in a clinical study done by Timmers et al. Obese patients, who received 150 mg of resveratrol per day for 30 days, have shown increased plasma levels of SIRT1 (98).